For research use only. Not for therapeutic Use.
Vixarelimab（Cat No.:I042135）is a monoclonal antibody designed to target and inhibit the activity of OX40L, a protein involved in the activation and regulation of immune cells, particularly T-cells. By blocking OX40L, Vixarelimab aims to modulate the immune response and reduce inflammation associated with various autoimmune diseases and allergic conditions. It is being investigated for the treatment of diseases like atopic dermatitis and other chronic inflammatory disorders. Early clinical trials have shown potential in improving symptoms, with ongoing research to evaluate its safety and effectiveness.
| CAS Number | 2243320-83-2 |
| Purity | ≥95% |
